Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics, a leader in cell therapy, has announced a $5 million capital raise and will host an investor webinar led by COO Dr. Rebecca McQualter to provide updates. The company is advancing its diversified portfolio of innovative cell therapies, including CAR T and NK cell therapies, which are in various stages of clinical trials targeting cancers. This strategic move and the ongoing trials highlight Chimeric’s dedication to pioneering breakthroughs in cancer treatment.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.